Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 9/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 7/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | TYR | P14679 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | AR | P10275 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | HTR6 | P50406 | 1/20 | 0.44 |
| ▸ | ESRRG | P62508 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7924649 | 0.89 | ALOX15 (0.52) | ESR1ESR2CYP3A4LMNATYR | |
| Dienestrol SCHEMBL5689185 | 0.84 | ESR1 (0.61) | ESR1ESR2CYP3A4LMNATYR | |
| SCHEMBL173365 | 0.79 | PREP (0.49) | ESR1ESR2CYP3A4LMNATYR | |
| SCHEMBL8278 | 0.78 | — | — | |
| SCHEMBL906834 | 0.76 | IDO1 (0.48) | ESR1ESR2CYP3A4LMNATYR | |
| Hydroxyamine SCHEMBL9902146 | 0.75 | — | — | |
| SCHEMBL5379895 | 0.74 | PREP (0.53) | ESR1ESR2MEN1KMT2AKDM4E | |
| SCHEMBL5609364 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL16047936 | 0.74 | — | — | |
| SCHEMBL10126374 | 0.73 | CA12 (0.52) | ESR1ESR2LMNATYRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7459284-B2 | Chemiluminescent acridinium compounds and analogues thereof as substrates of hydrolytic enzymes | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2008-12-02 | — | — | US | disclosed |
| US-20060202179-A1 | Chemiluminescent Acridinium Compounds and Analogues thereof as Substrates of Hydrolytic Enzymes | BAYER CORPORATION (US) | 2006-09-14 | — | — | US | disclosed |
| US-7097995-B2 | Chemiluminescent acridinium compounds and analogues thereof as substrates of hydrolytic enzymes | BAYER CORP. (US) | 2006-08-29 | — | — | US | disclosed |
| EP-1203091-B1 | CHEMILUMINESCENT SUBSTRATES OF HYDROLYTIC ENZYMES SUCH AS PHOSPHATASES | BAYER AG (US) | 2005-03-16 | — | — | EP | disclosed |
| US-20050032147-A1 | Chemiluminescent acridinum compounds and analogues thereof as substrates of hydrolytic enzymes | BAYER CORPORATION | 2005-02-10 | — | — | US | disclosed |
| US-6783948-B1 | USED IN DIAGNOSTIC IMMUNOASSAYS; HAS DISTINCTLY DIFFERENT LIGHT EMISSION CHARACTERISTICS (EMISSION WAVELENGTH, KINETICS, OR QUANTUM YIELD) | BAYER CORPORATION | 2004-08-31 | — | — | US | disclosed |
| EP-1203091-A1 | CHEMILUMINESCENT SUBSTRATES OF HYDROLYTIC ENZYMES SUCH AS PHOSPHATASES | Bayer Corporation (US) | 2002-05-08 | — | — | EP | disclosed |
| WO-2001009372-A1 | CHEMILUMINESCENT SUBSTRATES OF HYDROLYTIC ENZYMES SUCH AS PHOSPHATASES | BAYER CORPORATION (US) | 2001-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050032147-A1 | Chemiluminescent acridinum compounds and analogues thereof as substrates of hydrolytic enzymes | MPO, LPO, PGLS | ESR1 862/4885ESR2 1888/4885CYP3A4 266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.